Browsing byAuthorKermeen, M
Showing results 1 to 5 of 5
| Issue Date | Title | Author(s) |
| 2018-07-01 | Utilisation of hepatocellular carcinoma screening in Australians at risk of hepatitis B virus-related carcinoma and prescribed anti-viral therapy | Sheppard-Law, S; Zablotska-Manos, I; Kermeen, M; Holdaway, S; Lee, A; George, J; Zekry, A; Maher, L |
| 2018-01-01 | Factors associated with non-adherence to HBV antiviral therapy | Sheppard-Law, S; Zablotska-Manos, I; Kermeen, M; Holdaway, S; Lee, A; George, J; Zekry, A; Maher, L |
| 2017-01-01 | Factors associated with HBV virological breakthrough | Sheppard-Law, S; Zablotska-Manos, I; Kermeen, M; Holdaway, S; Lee, A; Zekry, A; Dore, GJ; George, J; Maher, L |
| 2016-01-01 | Concordance between missed days of hepatitis B virus anti-viral therapy and virological breakthrough | Sheppard-Law, SJ; Kermeen, M; Holdaway, S; Zekry, A; George, J; Dore, GJ; Maher, L |
| 2016-01-01 | Factors associated with adherence to hepatocellular carcinoma surveillance in patients under going hepatitis B anti-viral therapy in Australia | Sheppard-Law, SJ; Zablotska-Manos, I; Kermeen, M; Holdaway, S; Lee, A; Zekry, A; George, J; Maher, L |
